About the journal
Pharmaceuticals is an open-access journal published by MDPI AG in Switzerland, publishing in english. It is listed in DOAJ and PUBMED according to the sources read. Declared publication charge: 2,900 CHF. Declared review time at DOAJ: 6 weeks. Facts are reproduced as recorded at their sources with their capture dates; PublishLens indicators are available after sign-in.
Basic facts
- Publisher
- MDPI AG
- ISSN
- 1424-8247
- Country
- Switzerland
- Languages
- english
- Access
- Open access
- Declared publication charge
- 2,900 CHF
- Articles in DOAJ
- 11125
- Declared review time
- 6 weeks
- Declared peer-review model
- peer_review
- Official website
- http://www.mdpi.com/journal/pharmaceuticals/
Index listings
- DOAJ · 2005-01-21
- PUBMED · 2009-04-01
- Indexing
- DOAJ · PUBMED
- APC
- 2,900 CHF
- Declared review time (DOAJ)
- 6 weeks — journal-declared only (not measured)
- Activity (OpenAlex)
- Active — latest works 2026
- PublishLens list status
- Shown after sign-in
- Counts for promotion at your university?
- Choose your university and rank below ↓
Methodology signals (dated facts from their sources)
Details of the evaluation under the published methodology are shown to signed-in users (free).
Create a free account to view the evaluationJournal profile
Descriptive metadata from public sources (DOAJ, OpenAlex, PubMed) as of the capture date shown — contains no assessment or judgment.
Articles in DOAJ
11125
Most recent article
2 months ago
Average review time (journal-declared via DOAJ)
6weeks
Works in OpenAlex
10810
Last recorded publication year
2026
h-index
139
i10-index
4882
From OpenAlex open data (CC0).
Editorial & policy13
- Last DOAJ review date
- 2024-04-10
- Added to DOAJ
- 2005-01-21
- Declared plagiarism screening
- Declared
- Other fees beyond APC
- No
- Declared digital preservation
- CLOCKSS
- Observed digital preservation (Keepers registry)— snapshot 2026-10-05
- CLOCKSS
- Editorial board
- Official page ↗
- Norwegian register (HK-dir)— 2026
- Level 1 — approved scholarly channel
- Open references deposited at Crossref
- 99%
- ORCID iDs in current deposits
- 94%
- Enrolled in Crossref Similarity Check
- ✓
- Deposits licence metadata at Crossref
- ✓
- APC waiver policy
- View policy
- Peer-review policy
- View policy
Identity & continuity2
- Source type
- journal
- NLM unique ID (PubMed)
- 101238453
Classification3
Subjects (DOAJ)
LCC codes
Subject areas
- Computational Drug Discovery Methods
- Computational Drug Discovery Methods
- Synthesis and biological activity
- Synthesis and biological activity
- Essential Oils and Antimicrobial Activity
- Essential Oils and Antimicrobial Activity
- Advanced Drug Delivery Systems
- Phytochemicals and Antioxidant Activities
Show all subjects (50)
- Advanced Drug Delivery Systems
- Phytochemicals and Antioxidant Activities
- Pharmacological Effects of Natural Compounds
- Pharmacological Effects of Natural Compounds
- Radiopharmaceutical Chemistry and Applications
- Radiopharmaceutical Chemistry and Applications
- RNA Interference and Gene Delivery
- RNA Interference and Gene Delivery
- Tryptophan and brain disorders
- Nanoparticle-Based Drug Delivery
- Natural product bioactivities and synthesis
- Natural product bioactivities and synthesis
- Peptidase Inhibition and Analysis
- Tryptophan and brain disorders
- Peptidase Inhibition and Analysis
- Nanoparticle-Based Drug Delivery
- Monoclonal and Polyclonal Antibodies Research
- Neuroscience and Neuropharmacology Research
- Monoclonal and Polyclonal Antibodies Research
- Neuroscience and Neuropharmacology Research
- Advancements in Transdermal Drug Delivery
- Click Chemistry and Applications
- Cannabis and Cannabinoid Research
- Click Chemistry and Applications
- Advancements in Transdermal Drug Delivery
- Cannabis and Cannabinoid Research
- Drug Solubulity and Delivery Systems
- Drug Solubulity and Delivery Systems
- Phytochemistry and Biological Activities
- Nanoplatforms for cancer theranostics
- Phytochemistry and Biological Activities
- Nanoplatforms for cancer theranostics
- Cancer therapeutics and mechanisms
- Cancer therapeutics and mechanisms
- Cholinesterase and Neurodegenerative Diseases
- Advanced biosensing and bioanalysis techniques
- Advanced biosensing and bioanalysis techniques
- Cholinesterase and Neurodegenerative Diseases
- Synthesis and Biological Evaluation
- Synthesis and Biological Evaluation
- Antimicrobial Peptides and Activities
- Antimicrobial Peptides and Activities
Keywords (DOAJ)
- drugs
Community confirmations — what users saw in MJL or Scopus Sources; not platform verification and never part of any score.
The journal's record in other sources:Web of Science MJLDOAJ